Bisgaard A, Brink C, Schytte T, Bahij R, Weisz Ejlsmark M, Bernchou U
Front Oncol. 2024; 14:1401464.
PMID: 39091912
PMC: 11291378.
DOI: 10.3389/fonc.2024.1401464.
Kang H
Acta Radiol Open. 2024; 13(6):20584601241246105.
PMID: 38835950
PMC: 11149450.
DOI: 10.1177/20584601241246105.
Mohammadi M, Banisharif S, Moradi F, Zamanian M, Tanzifi G, Ghaderi S
Rep Pract Oncol Radiother. 2024; 28(6):823-834.
PMID: 38515826
PMC: 10954263.
DOI: 10.5603/rpor.98728.
Zhang M, Liu X, Du Y, Zha H, Zha X, Wang J
Br J Radiol. 2024; 97(1153):228-236.
PMID: 38263817
PMC: 11027305.
DOI: 10.1093/bjr/tqad014.
Schillmaier M, Kaika A, Topping G, Braren R, Schilling F
MAGMA. 2023; 36(6):957-974.
PMID: 37436611
PMC: 10667135.
DOI: 10.1007/s10334-023-01107-w.
High predictive ability of apparent diffusion coefficient value for wall-invasion pattern of advanced gallbladder carcinoma.
Koga T, Ishida Y, Hamada Y, Takayama Y, Tsuchiya N, Kitaguchi T
Abdom Radiol (NY). 2023; 48(3):902-912.
PMID: 36694054
DOI: 10.1007/s00261-023-03805-4.
Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma.
Qu C, Zeng P, Wang H, Guo L, Zhang L, Yuan C
Cancers (Basel). 2022; 14(17).
PMID: 36077777
PMC: 9454581.
DOI: 10.3390/cancers14174243.
Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy.
Lee H, Kim H, Choi Y, Pyo H, Ahn M, Choi J
Cancers (Basel). 2022; 14(15).
PMID: 35954472
PMC: 9367384.
DOI: 10.3390/cancers14153809.
Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization.
Schmidt V, Schirren M, Heimer M, Kazmierczak P, Cyran C, Wildgruber M
Diagnostics (Basel). 2022; 12(3).
PMID: 35328138
PMC: 8946889.
DOI: 10.3390/diagnostics12030585.
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies.
Ellingson B, Wen P, Cloughesy T
Cancer J. 2021; 27(5):395-403.
PMID: 34570454
PMC: 8480435.
DOI: 10.1097/PPO.0000000000000543.
T2-FLAIR, DWI and DKI radiomics satisfactorily predicts histological grade and Ki-67 proliferation index in gliomas.
Su C, Chen X, Liu C, Li S, Jiang J, Qin Y
Am J Transl Res. 2021; 13(8):9182-9194.
PMID: 34540034
PMC: 8430185.
Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses.
Usuda K, Iwai S, Yamagata A, Iijima Y, Motono N, Matoba M
Cancers (Basel). 2021; 13(15).
PMID: 34359616
PMC: 8345147.
DOI: 10.3390/cancers13153713.
Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis Imaging.
Li Y, Kim M, Wahl D, Lawrence T, Parmar H, Cao Y
Front Oncol. 2021; 11:690036.
PMID: 34336676
PMC: 8316991.
DOI: 10.3389/fonc.2021.690036.
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer.
Puranik A, Dromain C, Fleshner N, Sathekge M, Pavel M, Eberhardt N
Cancers (Basel). 2021; 13(14).
PMID: 34298822
PMC: 8304541.
DOI: 10.3390/cancers13143607.
How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio.
Usuda K, Iwai S, Yamagata A, Iijima Y, Motono N, Doai M
Clin Med Insights Oncol. 2021; 15:11795549211014863.
PMID: 34285624
PMC: 8267030.
DOI: 10.1177/11795549211014863.
Magnetic Resonance Imaging for Drug Development.
Kim J
Adv Exp Med Biol. 2021; 1310:187-209.
PMID: 33834438
DOI: 10.1007/978-981-33-6064-8_9.
Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses.
Usuda K, Ishikawa M, Iwai S, Iijima Y, Motono N, Matoba M
Cancers (Basel). 2021; 13(7).
PMID: 33800560
PMC: 8037373.
DOI: 10.3390/cancers13071551.
Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging.
Hesse F, Somai V, Kreis F, Bulat F, Wright A, Brindle K
Proc Natl Acad Sci U S A. 2021; 118(12).
PMID: 33727417
PMC: 8000230.
DOI: 10.1073/pnas.2014631118.
High-frequency electrical properties tomography at 9.4T as a novel contrast mechanism for brain tumors.
Lesbats C, Katoch N, Minhas A, Taylor A, Kim H, Woo E
Magn Reson Med. 2021; 86(1):382-392.
PMID: 33533114
PMC: 8603929.
DOI: 10.1002/mrm.28685.
Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman C, Tanyeri A, Ozgur R, Ozturk V
Dentomaxillofac Radiol. 2020; 50(4):20200391.
PMID: 33237812
PMC: 8077997.
DOI: 10.1259/dmfr.20200391.